Pharmacodynamic/Pharmacokinetic Case Study
Write a 3-page cardboard APA in-text citations, 4 references that addresses the following:
Explain how the agency you called ability access the pharmacokinetic and pharmacodynamic processes in the case abstraction below:
Patient HM has a history of atrial fibrillation and a brief ischemic advance (TIA). The accommodating has been diagnosed with blazon 2 diabetes, hypertension, hyperlipidemia and ischemic affection disease. Drugs currently assigned accommodate the following:
Warfarin 5 mg circadian MWF and 2.5 mg circadian T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 1–3 tablets every 6 hours as bare for pain.
Select one the afterward factors: genetics, gender, ethnicity, age, or behavior factors.
Reflect on how the agency you called ability access the patient’s pharmacokinetic and pharmacodynamic processes.
Consider how changes in the pharmacokinetic and pharmacodynamic processes ability appulse the patient’s recommended biologic therapy.
Think about how you ability advance the patient’s biologic analysis plan based on the pharmacokinetic and pharmacodynamic changes.
Reflect on whether you would adapt the accepted biologic analysis or accommodate an another analysis advantage for the patient.
Describe how changes in the processes ability appulse the patient’s recommended biologic therapy.
Be specific and accommodate examples.
Explain how you ability advance the patient’s biologic analysis plan and explain why you would accomplish these recommended improvements.
Order a unique copy of this paper